Human immunodeficiency virus-1 (HIV-1) exploits human host factors to complete its life cycle. Hence, it is very important to identify HIV-regulated host proteins for better understanding of the virus life cycle and its contribution to pathogenesis. This can potentially lead to identifying core target molecules that can be used as diagnostic and prognostic markers and/or as targets for potential therapeutic intervention. We present here a first holistic attempt to apply global plasma proteomics analysis of three closely related study populations including: 1) patients with HIV type 1 (HIV-1), 2) HIV-1 elite controllers (HIV-1 EC), and 3) patients infected with HIV type 2 (HIV-2). Peripheral blood plasma (PBP) samples from these groups of patients, together with healthy donors, were subjected to expression proteomics using label-free quantitative liquid chromatography tandem mass spectrometry (LC-MS/MS). Over 314 unique PBP protein species were identified of which 100 (approx. 32%) were significantly differentially expressed (≥ 2 to ∞ - fold change; p < 0.05) between HIV-1, HIV-2 and HIV-1 EC control subjects. A total of 91 of the 100 proteins were significantly differentially expressed between pairs of HIV-1 versus HIV-1 EC, while 83 of the 100 proteins differed significantly between HIV-2 and HIV-1 EC. Interestingly, 76 proteins (87.5%) overlap between the two data sets indicating that majority of these proteins share similar expression changes between the three sample groups. Two proteins, XRCC5 and PSME1, were implicated in the early phase of the pathway network for HIV life cycle. Other identified proteins were involved in infectious disease and disease of signal transduction. Among them were MAP2K1, RPL23A, RPS3, RPS8, CALR, PRDX1, SOD2, LMNB1, LMNA, PHB, FGA, and FGB. Interestingly, despite high degree of similarity in protein profiles of HIV-1 and HIV-2, we identified only six proteins with significant expression changes (P<0.05). These include ETFB, PHB2, S100A9, LMO2, PPP3R1 and Vif, a fragment of virion infectivity factor of HIV-1. In conclusion, we have identified HIV-related protein expression changes and these proteins once validated in large sample cohort might potentially be capable of early diagnosis and prognosis of HIV diseases and other related infectious diseases. Funding: We would like to acknowledge King Abdulaziz City of Science and Technology for funding this project, advanced Strategic Program, National plan for Science, Technology and Innovation (10-BIO 1340-46). Declaration of Interest: The authors declare no competing interests. Ethical Approval: This study was conducted in accordance with the Helsinki Declaration and approved by the Research Ethics Committee and Research Advisory Council (ORA # 2110 001). All participants provided written and signed informed consents that were obtained by the institutional (KFSHRC) IRB approval.